The Department of Cardiovascular Medicine, The University of Tokyo Hospital, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
Department of Rehabilitation Sciences, Graduate School of Medical Sciences, Kitasato University, Sagamihara, Kanagawa, Japan.
Sci Rep. 2022 Jul 8;12(1):11641. doi: 10.1038/s41598-022-13752-7.
Little is known regarding the relationship between self-reported gait speed and the subsequent risk of heart failure (HF) and cardiovascular disease (CVD). We sought to clarify the clinical utility of self-reported gait speed in primary CVD prevention settings. This is an observational cohort study using the JMDC Claims Database, which is an administrative health claims database. Data were collected between January 2005 and April 2020. Medical records of 2,655,359 participants without a prior history of CVD were extracted from the JMDC Claims Database. Gait speed was assessed using information from questionnaires provided at health check-ups, and study participants were categorized into fast or slow gait speed groups. The primary outcome was HF. The secondary outcomes included myocardial infarction (MI), angina pectoris (AP), and stroke. The median age was 45.0 years, and 55.3% of participants were men. 46.1% reported a fast gait speed. The mean follow-up period was 1180 ± 906 days. HF, MI, AP, and stroke occurred in 1.9%, 0.2%, 1.9%, and 1.0% of participants, respectively. Multivariable Cox regression analyses showed that, compared with slow gait speed, fast gait speed was associated with a lower incidence of HF, MI, AP, and stroke. The discriminative predictive ability for HF significantly improved by adding self-reported gait speeds to traditional risk factors (net reclassification improvement 0.0347, p < 0.001). In conclusion, our analysis demonstrated that subjective gait speed could be a simple method to stratify the risk of HF and other CVD events in the general population. Further investigations are required to clarify the underlying mechanism of our results and to develop a novel approach for primary CVD prevention.
关于自我报告的步速与心力衰竭 (HF) 和心血管疾病 (CVD) 风险之间的关系,知之甚少。我们旨在阐明自我报告的步速在 CVD 一级预防中的临床应用价值。这是一项使用 JMDC 理赔数据库的观察性队列研究,JMDC 理赔数据库是一个行政健康理赔数据库。数据收集于 2005 年 1 月至 2020 年 4 月期间。从 JMDC 理赔数据库中提取了 2655359 名无 CVD 既往史的参与者的医疗记录。使用健康检查时提供的问卷信息评估步速,研究参与者被分为快速或慢速步速组。主要结局为 HF。次要结局包括心肌梗死 (MI)、心绞痛 (AP) 和中风。中位年龄为 45.0 岁,55.3%的参与者为男性。46.1%报告了快速步速。平均随访时间为 1180±906 天。HF、MI、AP 和中风分别在 1.9%、0.2%、1.9%和 1.0%的参与者中发生。多变量 Cox 回归分析表明,与慢速步速相比,快速步速与 HF、MI、AP 和中风的发生率降低相关。与传统危险因素相比,加入自我报告的步速可显著提高 HF 的预测能力(净重新分类改善 0.0347,p<0.001)。总之,我们的分析表明,主观步速可能是一种简单的方法,可对一般人群 HF 和其他 CVD 事件的风险进行分层。需要进一步研究以阐明我们研究结果的潜在机制,并开发一种新的 CVD 一级预防方法。